Publication | Closed Access

Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group

OncologyGemcitabine CombinationMetronomic TherapyPhase Ii StudyBronchial NeoplasmFirst-line TreatmentCancer TreatmentMedicineRadiation OncologyLung CancerMolecular Oncology